# List of papers on computational immunology
>this repository is inspired by [Kevin Kaichuang Yang](https://github.com/yangkky) and [Sean Peldom Zhang](https://github.com/Peldom). Their works [Machine-learning-for-proteins](https://github.com/yangkky/Machine-learning-for-proteins) and [papers_for_protein_design_using_DL](https://github.com/Peldom/papers_for_protein_design_using_DL) are so unparalleled that I can't help but to follow their steps. I establish the repository mainly for systematically organizing these papers read by iqb members, so that anyone interested in cancer immunology and machine learning for protein can learn about the latest achievement in the field thorough the papers. I will try my best to keep this repository updated. <br>
If you have any questions, please contact me at [tintinjiangiwls@gmail.com] or Kevin Chun CHAN [kevin@skblnw.com].<br>

>Any contributions and suggestions are welcomed!ðŸŽ‰ðŸŽ‰ðŸ’—ðŸ’—<br>

>**Note**: The papers are sorted by their themes and the time they are published.

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #193441, #FCFFF5);">

## Content
- [Reviews and Surveys](#reviews-and-surveys)
    - [R-Intrinsic Disordered Protein](#r-intrinsic-disordered-protein)
    - [R-Cancer Immunology](#r-cancer-immunology)
    - [R-Model and Technology](#r-model-and-technology)
        - [R-Protein Language Model](#r-protein-language-model)
        - [R-Drug Design](#r-drug-design)
- [Intrinsic Disordered Protein](#intrinsic-disordered-protein)
- [Cancer Immunology](#cancer-immunology)
- [Model and Technology](#model-and-technology)
    - [protein language model](#model-and-technology)
- [Drug Design](#drug-design)
- [Covid-19](#covid-19)

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #FCFFF5, #193441);">

## Reviews-and-surveys

### R Intrinsic Disordered Protein

### R Cancer Immunology
- [Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions](https://www.frontiersin.org/articles/10.3389/fphar.2018.00185/full)<br>
    -frontiersin.org<br>
    -Published: 05 March 2018<br>
    -DOI: https://doi.org/10.3389/fphar.2018.00185<br>
    `Immunotherapy` `Radiotherapy` `Cancer Treatment`

- [Elements of cancer immunity and the cancerâ€“immune set point](https://www.nature.com/articles/nature21349)<br>
    -nature<br>
    -Published:18 January 2017<br>
    -DOI: https://doi.org/10.1038/nature21349<br>
    `cancer immunity` `cancerâ€“immune set point`
- [Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic](https://www.sciencedirect.com/science/article/pii/S0923753419309974)<br>
    -Annals of Oncology <br>
    -Published: January 2019<br>
    -DOI: https://doi.org/10.1093/annonc/mdy495<br>
    `Tumor mutation burden` `Immunotherapy` `Biomarker` `Oncology clinic`

- [T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy](https://www.frontiersin.org/articles/10.3389/fimmu.2022.833017/full)<br>
    -frontiersin.org<br>
    -Published: 10 February 2022<br>
    -DOI: https://doi.org/10.3389/fimmu.2022.833017<br>
    `T cell` `neoantigen` `immunotherapy`

### R Model and Technology
#### R Protein Language Model
- [Controllable protein design with language models](https://www.nature.com/articles/s42256-022-00499-z)<br>
    -Nature Machine Learning<br>
    -Published: 22 June 2022<br>
    -DOI: https://doi.org/10.1038/s42256-022-00499-z<br>
    `protein language model` `protein design` `deep learning`

- [Linguistically inspired roadmap for building biologically reliable protein language models](https://www.nature.com/articles/s42256-023-00637-1)<br>
    -Nature Machine Learning<br>
    -Published: 06 April 2023<br>
    -DOI: https://doi.org/10.1038/s42256-023-00637-1<br>
    `protein language model` `protein design` `deep learning`

- [On scientific understanding with artificial intelligence](https://www.nature.com/articles/s42254-022-00518-3)<br>
    -nature reviews physics <br>
    -Published: 11 October 2022<br>
    -DOI: https://doi.org/10.1038/s42254-022-00518-3<br>
    `scientific understanding` `artificial intelligence`

#### R Drug Design
- [Deep Generative Molecular Design Reshapes Drug Discovery](https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(22)00349-4.pdf)<br>
    -Cell Reports Medicine<br>
    -Published: 20 December 2022<br>
    -DOI: https://doi.org/10.1016/j.xcrm.2022.100794<br>
    `generative model` `drug design` `deep learning`


<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #193441, #FCFFF5);">

## Intrinsic Disordered Protein

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #FCFFF5, #193441);">

## Cancer Immunology
- [HLA supertypes and supermotifs: a functional perspective on HLA polymorphism](https://www.sciencedirect.com/science/article/abs/pii/S0952791598801246)<br>
    -Current Opinion in Immunology<br>
    -Published: August 1998<br>
    -DOI: https://doi.org/10.1016/S0952-7915(98)80124-6<br>
    `HLA` `supertypes` `supermotifs` `HLA polymorphism`

- [Distinct Molecular Mechanisms Account for the Specificity of Two Different T-Cell Receptors](https://pubs.acs.org/doi/abs/10.1021/bi026864+?casa_token=OWz2bpRMRKwAAAAA:nXnkLNSfGksVsMCXkytukGuvB0bF1ptncgCwB4Z8RyYNu_yq-7CAafXXLpjn9y21LNHdwbjsSzSlqg)<br>
    -Biochemistry<br>
    -Published: 1 April 2003<br>
    -DOI: https://doi.org/10.1021/bi026864+<br>
    `T cell` `TCR` `specificity` `molecular mechanism`

- [Examining Variable Domain Orientations in Antigen Receptors Gives Insight into TCR-Like Antibody Design](https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1003852)<br>
    -PLOS Computational Biology<br>
    -Published: 18 September 2014<br>
    -DOI: https://doi.org/10.1371/journal.pcbi.1003852<br>
    `T cell` `TCR` `antibody design` `variable domain orientations`

- [Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens](https://www.nature.com/articles/nature13988)<br>
    -nature<br>
    -Published: 26 November 2014<br>
    -DOI: https://doi.org/10.1038/nature13988<br>
    `checkpoint blockade` `cancer immunotherapy` `tumour-specific mutant antigens`

- [A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells](https://www.science.org/doi/abs/10.1126/science.aaa3828)<br>
    -Science<br>
    -Published: 2 April 2015<br>
    -DOI: https://doi.org/10.1126/science.aaa3828<br>
    `dendritic cell vaccine` `melanoma` `neoantigen-specific T cells`

- [A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen](https://www.cell.com/cell/pdf/S0092-8674(19)30505-7.pdf)<br>
    -Cell<br>
    -Published: 30 May 2019<br>
    -DOI: https://doi.org/10.1016/j.cell.2019.02.007<br>
    `BCR` `T cell` `autoantigen` `Type 1 Diabetes`

- [Exploration of HIV-1 fusion peptideâ€“antibody VRC34.01 binding reveals fundamental neutralization sites](https://pubs.rsc.org/en/content/articlehtml/2019/cp/c9cp02909e?casa_token=gJS1Tj2xf-cAAAAA:dY5_PA4288jR8Uzd7mu_5haAurnpNY4DD2h0Q0hY74u-tGkg5CwdGTkG6t3ZpeFUbm3jPoYoE02M)<br>
    -Physical Chemistry Chemical Physics<br>
    -Published: 08 August 2019<br>
    -DOI: https://doi.org/10.1039/C9CP02909E<br>
    `HIV-1` `fusion peptide` `antibody` `neutralization sites`

- [A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease](https://www.pnas.org/doi/abs/10.1073/pnas.1914308117)<br>
    -PNAS<br>
    -Published: 23 January 2020<br>
    -DOI: https://doi.org/10.1073/pnas.1914308117<br>
    `Celiac Disease` `HLA-DQ2.2` `TCR` `Immunogenicity` `Gliadin Peptides`

- [Commensal bacteria stimulate antitumor responses via T cell cross-reactivity](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205429/)<br>
    -JCI Insight<br>
    -Published: 23 April 2020<br>
    -DOI: https://doi.org/10.1172/jci.insight.135597<br>
    `Commensal bacteria` `antitumor responses` `T cell cross-reactivity`

- [High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D](https://www.pnas.org/doi/abs/10.1073/pnas.1921964117)<br>
    -PNAS<br>
    -Published: 27 May 2020<br>
    -DOI: https://doi.org/10.1073/pnas.1921964117<br>
    `TCR` `T cell therapy` `mutant KRAS-G12D` `high-affinity oligoclonal`

- [Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T Cells](https://journals.aai.org/jimmunol/article/205/2/539/110175?casa_token=6XLQ4nJDd5MAAAAA:EpLWn0bx5osgeP1LOpCEQMVE34JJkOuOUUo_yZejq2pE7deTNxUjZlRjElPAVajGlV1Brg)<br>
    -the Journal of Immunology<br>
    -Published: 15 July 2020<br>
    -DOI: https://doi.org/10.4049/jimmunol.1901173<br>
    `MHC` `T cell` `cysteine residues` `binding predictions`

- [Canonical T cell receptor docking on peptideâ€“MHC is essential for T cell signaling](https://www.science.org/doi/full/10.1126/science.abe9124?casa_token=6E3TFOrwX9cAAAAA%3AG6c7m5C92BCPW0YTwEPXN3_YDcWtc3Jq0pxhu3TTEDHquzXGfmau37E5iZrmfK3rfY-DS-wzB-I_)<br>
    -Science<br>
    -Published: 04 June 2020<br>
    -DOI: https://doi.org/10.1126/science.abe9124<br>
    `T cell receptor` `peptideâ€“MHC` `T cell signaling`

- [Dynamics-Based Peptideâ€“MHC Binding Optimization by a Convolutional Variational Autoencoder: A Use-Case Model for CASTELO](https://pubs.acs.org/doi/full/10.1021/acs.jctc.1c00870)<br>
    -Journal of Chemical Theory and Computation<br>
    -Published: 18 November 2021<br>
    -DOI: https://doi.org/10.1021/acs.jctc.1c00870<br>
    `MHC` `T cell` `binding predictions` `convolutional variational autoencoder`

- [Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens](https://academic.oup.com/bib/article/23/3/bbac141/6573960)<br>
    -Briefings in Bioinformatics<br>
    -Published: 25 April 2022<br>
    -DOI: https://doi.org/10.1093/bib/bbac141<br>
    `CD8+ T cell` `pathogenic epitopes` `cancer neoantigens` `computational models`

- [Specific Genetic Polymorphisms Contributing in Differential Binding of Gliadin Peptides to HLA-DQ and TCR to Elicit Immunogenicity in Celiac Disease](https://link.springer.com/article/10.1007/s10528-023-10377-x#Abs1)<br>
    -Biochemical Genetics<br>
    -Published: 27 April 2023<br>
    -DOI: https://doi.org/10.1007/s10528-023-10377-x<br>
    `Celiac Disease` `HLA-DQ` `TCR` `Immunogenicity` `Gliadin Peptides`

- [Pan-KRAS inhibitor disables oncogenic signalling and
tumour growth](https://www.nature.com/articles/s41586-023-06123-3)<br>
    -nature<br>
    -Published: 31 May 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06123-3<br>
    `KRAS` `pan-KRAS inhibitor` `oncogenic signalling` `tumour growth`

- [A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection](https://www.nature.com/articles/s41586-023-06331-x)<br>
    -nature<br>
    -Published: 19 July 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06331-x<br>
    `HLA` `SARS-CoV-2` `asymptomatic infection`

- [A membrane-associated MHC-I inhibitory axis for cancer immune evasion](https://www.cell.com/cell/pdf/S0092-8674(23)00783-3.pdf)<br>
    -Cell<br>
    -Published: 8 August 2023<br>
    -DOI: https://doi.org/10.1016/j.cell.2023.07.026<br>
    `MHC-I` `cancer immune evasion` `membrane-associated` `inhibitory axis`

- [Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS](https://www.science.org/doi/full/10.1126/science.adg9652?casa_token=YZtzYJhYntkAAAAA%3A7WsUudgDlDa7X4etI_e0axz0QsYmWa7wjhMeFC_aYvrMhx0O7_gMCDCLxzsYXIYm6RfN-hmPzYiA)<br>
    -Science<br>
    -Published: 17 August 2023<br>
    -DOI: https://doi.org/10.1126/science.adg9652<br>
    `KRAS` `chemical remodeling` `chaperone`

- [Quantitative approaches for decoding the specificity of the human T cell repertoire](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539903/)<br>
    -frontiers in immunology<br>
    -Published: 7 September 2023<br>
    -DOI: https://doi.org/10.3389%2Ffimmu.2023.1228873<br>
    `T cell` `TCR` `specificity` `quantitative approaches`

- [Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses](https://www.nature.com/articles/s41587-023-01957-8)<br>
    -Nature Biotechnology<br>
    -Published: 25 September 2023<br>
    -DOI: https://doi.org/10.1038/s41587-023-01957-8<br>
    `tumor-associated bacteria` `liposomal antibiotic` `neoantigens` `anti-tumor immune responses`

- [The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity](https://www.nature.com/articles/s41586-023-06575-7)<br>
    -Nature<br>
    -Published: 04 October 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06575-7<br>
    `PTPN2` `PTPN1` `ABBV-CLS-484` `anti-tumour immunity`

- [Cancer- and infection-induced T cell exhaustion are distinct](https://www.nature.com/articles/s41590-023-01624-9)<br>
    -nature immunology<br>
    -Published: 14 November 2023<br>
    -DOI: https://doi.org/10.1038/s41590-023-01624-9<br>
    `T cell` `exhaustion` `cancer` `infection`

- [Targeting of intracellular oncoproteins with peptide-centric CARs](https://www.nature.com/articles/s41586-023-06706-0)<br>
    -nature<br>
    -Published: 08 November 2023<br>
    -DOI: https://doi.org/10.3389%2F<br>
    `peptide-centric chimeric antigen receptors `

- [Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule tar- geting CD47 for lung cancer immunotherapy](https://www.nature.com/articles/s41467-023-42972-2)<br>
    -nature communications<br>
    -Published: 11 November 2023<br>
    -DOI: https://doi.org/10.1038/s41467-023-42972-2<br>
    `calcium channel inhibitor` `CD47` `lung cancer immunotherapy` `nanomedicine`

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #193441, #FCFFF5);">

## Model and Technology
### protein language model
- [DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning](https://academic.oup.com/bioinformatics/article/36/19/4894/5864021)<br>
    -Bioinformatics<br>
    -Published: 11 September 2020<br>
    -DOI: https://doi.org/10.1093/bioinformatics/btaa686<br>
    `neoantigen` `3D genome` `deep sparse learning`

- [Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens](https://academic.oup.com/bib/article/23/3/bbac141/6573960)<br>
    -Briefings in Bioinformatics<br>
    -Published: 25 April 2022<br>
    -DOI: https://doi.org/10.1093/bib/bbac141<br>
    `CD8+ T cell` `pathogenic epitopes` `cancer neoantigens` `computational models`

- [ProtGPT2 is a deep unsupervised language model for protein design](https://www.nature.com/articles/s41467-022-32007-7)<br>
    -nature communications<br>
    -Published: 27 July 2022<br>
    -DOI: https://doi.org/10.1038/s41467-022-32007-7<br>
    `protein language model` `protein design` `deep learning`

- [Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences](https://www.nature.com/articles/s41551-022-00991-2)<br>
    -Nature Biomedical Engineering<br>
    -Published: 12 January 2023<br>
    -DOI: https://doi.org/10.1038/s41551-022-00991-2<br>
    `antimicrobial peptides` `machine-learning pipeline` `peptide sequences`

- [Efficient evolution of human antibodies from general protein language models](https://www.nature.com/articles/s41587-023-01763-2)<br>
    -Nature Biotechnology<br>
    -Published: 24 April 2023<br>
    -DOI: https://doi.org/10.1038/s41587-023-01763-2<br>
    `protein language model` `antibody design` `deep learning`

- [Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations](https://www.nature.com/articles/s41467-022-29331-3)<br>
    -nature communications<br>
    -Published: 29 March 2022<br>
    -DOI: https://doi.org/10.1038/s41467-022-29331-3<br>
    `protein` `allosteric interactions` `molecular dynamics simulations` `neural network`

- [Chemical complexity challenge: Is multi-instance machine learning a solution?](https://wires.onlinelibrary.wiley.com/doi/full/10.1002/wcms.1698)<br>
    -WIREs Computational Molecular Science<br>
    -Published: 27 November 2023<br>
    -DOI: https://doi.org/10.1002/wcms.1698<br>
    `multi-instance machine learning` `chemical complexity`

- [TCR-H: Machine Learning Prediction of T-cell Receptor Epitope Binding on Unseen Datasets](https://www.biorxiv.org/content/10.1101/2023.11.28.569077v1)<br>
    -bioRxiv<br>
    -Published: 28 November 2023<br>
    -DOI: https://doi.org/10.1101/2023.11.28.569077<br>
    `TCR` `machine learning` `negative data bias`
 

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #FCFFF5, #193441);">

## Drug Design

- [m<sup>1</sup>A in CAG repeat RNA binds to TDP-43 and induces neurodegeneration](https://www.nature.com/articles/s41586-023-06701-5)<br>
    -nature<br>
    -Published: 08 November 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06701-5<br>
    `m1A` `CAG repeat RNA` `TDP-43` `neurodegeneration`
  
<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #FCFFF5, #193441);">

## Covid-19
- [Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor](https://www.nature.com/articles/s41586-020-2180-5)<br>
    -Nature<br>
    -Published: 30 March 2020<br>
    -DOI: http://dx.doi.org/10.1038/s41586-020-2180-5"<br>
    `SARS-COV-2` `ACE2` `spike protein` `receptor-binding domain` `crystal structure`















